Diabetes Duration, Cholesterol Levels, and Risk of Cardiovascular Diseases in Individuals With Type 2 Diabetes.

Mee Kyoung Kim, Kyu Na Lee, Kyungdo Han, Seung-Hwan Lee
Author Information
  1. Mee Kyoung Kim: Division of Endocrinology and Metabolism, Department of Internal Medicine, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 07345, Republic of Korea. ORCID
  2. Kyu Na Lee: Department of Statistics and Actuarial Science, Soongsil University, Seoul 07040, Korea.
  3. Kyungdo Han: Department of Statistics and Actuarial Science, Soongsil University, Seoul 07040, Korea. ORCID
  4. Seung-Hwan Lee: Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea. ORCID

Abstract

OBJECTIVE: To investigate the association of diabetes duration with cardiovascular disease (CVD) risk and to examine the relationship between lipid levels and CVD risk over the duration.
METHODS: Using the Korean National Health Insurance Service Cohort database, we identified 2 359 243 subjects with type 2 diabetes aged ������20 years in 2015 to 2016. Baseline lipid levels and diabetes duration were evaluated and followed up until December 2020 (mean follow-up, 3.9 years). Subjects were categorized according to diabetes duration (new-onset, < 5 years, 5-9 years, or ������10 years). We analyzed the new-onset diabetes group with low-density lipoprotein cholesterol (LDL-C) < 70���mg/dL as the reference group. The hazard ratios (HRs) and 95% CIs of myocardial infarction (MI) and ischemic stroke (IS) were estimated using a Cox proportional hazards model adjusted for potential confounders.
RESULTS: During follow-up, 45 883 cases of MI and 53 538 cases of IS were identified. The risk of MI or IS began to increase at LDL-C ������160���mg/dL in the new-onset diabetes group, and at LDL-C ������130���mg/dL in the group with diabetes duration <���5 years. Among subjects with diabetes duration of 5 to 9 years, LDL-C levels of 100-129���mg/dL, 130-159���mg/dL, and ������160���mg/dL were significantly associated with the risk of MI (HR [95% CI] 1.13 [1.04-1.22], 1.28 [1.17-1.39], and 1.58 [1.42-1.76], respectively). MI risk in the diabetes duration ������10 years group was increased by 16%, even in the LDL-C 70-99���mg/dL population (HR [95% CI] 1.16 [1.08-1.25]).
CONCLUSION: This population-based longitudinal study revealed that the LDL-C cutoff level for increasing the risk of CVD varied with diabetes duration and that the target LDL-C level should depend on the duration.

Keywords

References

  1. Diabetes Care. 2004 Mar;27(3):704-8 [PMID: 14988289]
  2. Eur Heart J. 2020 Jan 7;41(2):255-323 [PMID: 31497854]
  3. Endocrinol Metab (Seoul). 2023 Feb;38(1):10-24 [PMID: 36758542]
  4. Diabetes Care. 2023 Jan 1;46(Suppl 1):S97-S110 [PMID: 36507646]
  5. Nat Rev Endocrinol. 2020 Jun;16(6):321-331 [PMID: 32203408]
  6. Diabetes Metab J. 2022 Jul;46(4):552-563 [PMID: 35929173]
  7. Korean Circ J. 2020 Sep;50(9):754-772 [PMID: 32725984]
  8. Diabetes Obes Metab. 2021 Jun;23(6):1361-1370 [PMID: 33620747]
  9. J Diabetes Complications. 2022 Feb;36(2):108124 [PMID: 35063341]
  10. Diabetes Res Clin Pract. 2022 Jun;188:109899 [PMID: 35525499]
  11. Diabetes Metab J. 2023 Sep;47(5):575-594 [PMID: 37793979]
  12. Prog Cardiovasc Dis. 2017 Nov - Dec;60(3):422-434 [PMID: 28958751]
  13. Stroke. 2012 May;43(5):1212-7 [PMID: 22382158]
  14. N Engl J Med. 2005 Dec 22;353(25):2643-53 [PMID: 16371630]
  15. Front Endocrinol (Lausanne). 2023 May 08;14:1131395 [PMID: 37223032]
  16. Am J Med. 2014 Jul;127(7):616-24 [PMID: 24680795]
  17. Endocrinol Metab (Seoul). 2023 Aug;38(4):426-435 [PMID: 37469033]
  18. BMJ Open. 2016 Dec 9;6(12):e012413 [PMID: 27940627]
  19. Endocrinol Metab (Seoul). 2022 Feb;37(1):26-37 [PMID: 35255599]
  20. Lipids. 2010 Apr;45(4):321-7 [PMID: 20224977]
  21. Circulation. 2019 Sep 10;140(11):e563-e595 [PMID: 30879339]
  22. Circ Cardiovasc Interv. 2009 Dec;2(6):543-8 [PMID: 20031772]
  23. Respir Res. 2023 Apr 11;24(1):110 [PMID: 37041513]
  24. J Clin Endocrinol Metab. 2024 Nov 18;109(12):e2317-e2323 [PMID: 38366387]

Grants

  1. /Korean Society of Lipid and Atherosclerosis

MeSH Term

Humans
Male
Female
Diabetes Mellitus, Type 2
Middle Aged
Cardiovascular Diseases
Republic of Korea
Adult
Aged
Time Factors
Follow-Up Studies
Risk Factors
Cholesterol, LDL
Cholesterol
Myocardial Infarction
Proportional Hazards Models

Chemicals

Cholesterol, LDL
Cholesterol

Word Cloud

Created with Highcharts 10.0.0diabetesdurationyearsLDL-CriskgroupMI1[1CVDlevels2new-onsetIScardiovasculardiseaselipididentifiedsubjectsfollow-up9<5������10cholesterolcases������160���mg/dLHR[95%CI]levelDiabetesOBJECTIVE:investigateassociationexaminerelationshipMETHODS:UsingKoreanNationalHealthInsuranceServiceCohortdatabase359243typeaged������2020152016BaselineevaluatedfollowedDecember2020mean3Subjectscategorizedaccording5-9analyzedlow-densitylipoprotein70���mg/dLreferencehazardratiosHRs95%CIsmyocardialinfarctionischemicstrokeestimatedusingCoxproportionalhazardsmodeladjustedpotentialconfoundersRESULTS:4588353538beganincrease������130���mg/dL<���5Among100-129���mg/dL130-159���mg/dLsignificantlyassociated1304-122]2817-139]5842-176]respectivelyincreased16%even70-99���mg/dLpopulation1608-125]CONCLUSION:population-basedlongitudinalstudyrevealedcutoffincreasingvariedtargetdependDurationCholesterolLevelsRiskCardiovascularDiseasesIndividualsTypeKoreamellitus

Similar Articles

Cited By (2)